DK103891A - Intralaesional behandling af pladeepitelcarcinoma med rekombinant human alfainterferon - Google Patents

Intralaesional behandling af pladeepitelcarcinoma med rekombinant human alfainterferon Download PDF

Info

Publication number
DK103891A
DK103891A DK103891A DK103891A DK103891A DK 103891 A DK103891 A DK 103891A DK 103891 A DK103891 A DK 103891A DK 103891 A DK103891 A DK 103891A DK 103891 A DK103891 A DK 103891A
Authority
DK
Denmark
Prior art keywords
recombinant human
carcinoma
pladeepetal
intralaesional
alfainterferon
Prior art date
Application number
DK103891A
Other languages
English (en)
Other versions
DK103891D0 (da
Inventor
Daniel J Tanner
Edwin A Peets
Kenneth A Smiles
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of DK103891A publication Critical patent/DK103891A/da
Publication of DK103891D0 publication Critical patent/DK103891D0/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DK911038A 1988-12-01 1991-05-31 Intralaesional behandling af pladeepitelcarcinoma med rekombinant human alfainterferon DK103891D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27831588A 1988-12-01 1988-12-01
PCT/US1989/005287 WO1990006135A1 (en) 1988-12-01 1989-11-29 Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon

Publications (2)

Publication Number Publication Date
DK103891A true DK103891A (da) 1991-05-31
DK103891D0 DK103891D0 (da) 1991-05-31

Family

ID=23064525

Family Applications (1)

Application Number Title Priority Date Filing Date
DK911038A DK103891D0 (da) 1988-12-01 1991-05-31 Intralaesional behandling af pladeepitelcarcinoma med rekombinant human alfainterferon

Country Status (14)

Country Link
EP (2) EP0372809B1 (da)
JP (1) JPH0647556B2 (da)
KR (1) KR950011889B1 (da)
AT (1) ATE92333T1 (da)
AU (1) AU634511B2 (da)
CA (1) CA2004202C (da)
DE (1) DE68908119T2 (da)
DK (1) DK103891D0 (da)
ES (1) ES2058555T3 (da)
IE (1) IE63121B1 (da)
IL (1) IL92495A (da)
MY (1) MY107071A (da)
WO (1) WO1990006135A1 (da)
ZA (1) ZA899113B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06503570A (ja) * 1990-12-14 1994-04-21 シェリング・コーポレーション 肺の悪性腫瘍類を治療するためのアルファーインターフェロンの経口投与
IL100415A0 (en) * 1990-12-21 1992-09-06 Schering Corp Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases
ATE229343T1 (de) * 1995-10-04 2002-12-15 Schering Corp Kombination von temozolomide und alpha-interferon zur behandlung von fortgeschrittenem krebs
US7294332B2 (en) 1995-10-04 2007-11-13 Schering Corporation Combination therapy (temozolomide and α-IFN) for advanced cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0077063B1 (en) * 1981-10-13 1988-03-16 Exovir, Inc. Interferon-containing compositions and the use of these compositions in the treatment of herpetic infections, pre-malignant skin lesions, skin malignancies and psoriasis
CA1295243C (en) * 1986-05-27 1992-02-04 Daniel J. Tanner Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon

Also Published As

Publication number Publication date
WO1990006135A1 (en) 1990-06-14
IL92495A0 (en) 1990-08-31
DE68908119T2 (de) 1993-11-18
MY107071A (en) 1995-09-30
EP0372809A1 (en) 1990-06-13
ZA899113B (en) 1990-08-29
AU634511B2 (en) 1993-02-25
CA2004202C (en) 2001-02-13
ATE92333T1 (de) 1993-08-15
IE63121B1 (en) 1995-03-22
KR950011889B1 (ko) 1995-10-12
AU4802590A (en) 1990-06-26
KR900701311A (ko) 1990-12-01
JPH0647556B2 (ja) 1994-06-22
JPH04500678A (ja) 1992-02-06
IE893828L (en) 1990-06-01
EP0446279A1 (en) 1991-09-18
DE68908119D1 (de) 1993-09-09
EP0372809B1 (en) 1993-08-04
ES2058555T3 (es) 1994-11-01
DK103891D0 (da) 1991-05-31
CA2004202A1 (en) 1990-06-01
IL92495A (en) 1995-05-26

Similar Documents

Publication Publication Date Title
DK486588D0 (da) Konjungater af cytokininer med immunglobuliner
NO176665C (no) Fremgangsmåte for fremstilling av ikke-glykosylert IL-6 og vektor for utskillelse derav
DK478786D0 (da) Cystein-forarmede muteiner af biologisk aktive humantumornekrosefaktorproteiner
ATE198627T1 (de) Lederbehandlung mit ausgewählten amphiphilen copolymeren
DK0911033T3 (da) Anvendelse af konsensusinterferon til reduktion af bivirkningerne af interferonbehandling i viral hepatitis
DK103891D0 (da) Intralaesional behandling af pladeepitelcarcinoma med rekombinant human alfainterferon
DK50987A (da) Polypeptid med plasminogenaktivatorvirkning
DK0382381T3 (da) Behandling af leukocyt-dysfunktion med GM-CSF
DK328088A (da) Farmaceutisk komposition til behandling af tumorer
DK31386A (da) Behandling af proliferative hudsygdomme
EP0248583A3 (en) Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
OA08768A (fr) Traitement du virus su SIDA par l'interféron alpha humain recombinant.
EP0276120A3 (en) Treatment of certain leukemias with a combination of gamma interferon and alpha interferon
DE3750248D1 (de) Zubereitung und Behandlung der Haut mit Human-Leukocyten-Interferon.
DE3767175D1 (de) Therapeutische zusammenstellungen auf basis von 3-alkoxyflavonen und derivate von 3-alkoxyflavonen.
DK527287D0 (da) Polypeptid med interleukin-2-aktiviteter
DK0381584T3 (da) Anvendelse af visse gamma-interferoner til behandling af ovariecancer
FI880891A7 (fi) Humaanikudoksen plasminogeenin rekombinanttiaktivaattorin koostumus.
DK0495721T3 (da) Anvendelsen af et polypeptid med en humant-interleukin-2-aktivitet til fremstilling af farmaceutiske præparater beregnet til behandling af pneumothorax
FI871737A0 (fi) Kraftanlaeggning med foerbraenning i en fluidiserad baedd.
ATE88090T1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment